Clinical study concerning anti-inflammatory effect of fixed dose therapy by budesonide/formoterol combination inhaler for moderate persistent asthmatics.
Not Applicable
- Conditions
- Bronchial asthma
- Registration Number
- JPRN-UMIN000011853
- Lead Sponsor
- ational Center for Global Health and Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Current smokers, those who had a smoking history (smoking index > 400) and patients with suspected COPD were excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FeNO, as a marker of airway inflammation
- Secondary Outcome Measures
Name Time Method asthma control test (ACT) score, and the number of SABA use